Insulin is the principal hormone responsible for preventing hyperglycemia, raising the question of whether PDE4 inhibition may elevate blood glucose levels by lowering serum insulin levels (e.g., reducing insulin release) or reducing the sensitivity of metabolic/peripheral tissues to insulin. Here, INS is linked to Hyperglycemia.